Clearside Biomedical (CLSD) Competitors $3.90 -0.89 (-18.52%) As of 03:13 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLSD vs. TCRX, ONCY, HLVX, COYA, SRZN, SAVA, ADAG, KALA, ATOS, and EXOZShould you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include TScan Therapeutics (TCRX), Oncolytics Biotech (ONCY), HilleVax (HLVX), Coya Therapeutics (COYA), Surrozen (SRZN), Cassava Sciences (SAVA), Adagene (ADAG), KALA BIO (KALA), Atossa Genetics (ATOS), and eXoZymes (EXOZ). These companies are all part of the "pharmaceutical products" industry. Clearside Biomedical vs. Its Competitors TScan Therapeutics Oncolytics Biotech HilleVax Coya Therapeutics Surrozen Cassava Sciences Adagene KALA BIO Atossa Genetics eXoZymes TScan Therapeutics (NASDAQ:TCRX) and Clearside Biomedical (NASDAQ:CLSD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk. Which has more volatility & risk, TCRX or CLSD? TScan Therapeutics has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Clearside Biomedical has a beta of 2.11, meaning that its stock price is 111% more volatile than the S&P 500. Does the media prefer TCRX or CLSD? In the previous week, Clearside Biomedical had 3 more articles in the media than TScan Therapeutics. MarketBeat recorded 4 mentions for Clearside Biomedical and 1 mentions for TScan Therapeutics. TScan Therapeutics' average media sentiment score of 1.89 beat Clearside Biomedical's score of -0.03 indicating that TScan Therapeutics is being referred to more favorably in the media. Company Overall Sentiment TScan Therapeutics Very Positive Clearside Biomedical Neutral Do analysts rate TCRX or CLSD? TScan Therapeutics presently has a consensus target price of $7.80, suggesting a potential upside of 357.75%. Clearside Biomedical has a consensus target price of $63.00, suggesting a potential upside of 1,513.32%. Given Clearside Biomedical's higher possible upside, analysts plainly believe Clearside Biomedical is more favorable than TScan Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TScan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Clearside Biomedical 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Is TCRX or CLSD more profitable? Clearside Biomedical has a net margin of -665.19% compared to TScan Therapeutics' net margin of -1,964.88%. Clearside Biomedical's return on equity of 0.00% beat TScan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets TScan Therapeutics-1,964.88% -63.33% -40.19% Clearside Biomedical -665.19%N/A -124.15% Do institutionals & insiders hold more shares of TCRX or CLSD? 82.8% of TScan Therapeutics shares are held by institutional investors. Comparatively, 18.8% of Clearside Biomedical shares are held by institutional investors. 4.4% of TScan Therapeutics shares are held by company insiders. Comparatively, 6.7% of Clearside Biomedical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, TCRX or CLSD? Clearside Biomedical has lower revenue, but higher earnings than TScan Therapeutics. Clearside Biomedical is trading at a lower price-to-earnings ratio than TScan Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTScan Therapeutics$2.82M34.29-$127.50M-$1.09-1.56Clearside Biomedical$1.66M184.69-$34.35M-$0.37-10.55 SummaryClearside Biomedical beats TScan Therapeutics on 9 of the 16 factors compared between the two stocks. Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLSD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLSD vs. The Competition Export to ExcelMetricClearside BiomedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$306.50M$3.11B$5.75B$10.26BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-10.5521.3775.2626.44Price / Sales184.69240.13456.1288.47Price / CashN/A44.4425.8129.91Price / Book-7.669.6413.256.27Net Income-$34.35M-$53.20M$3.29B$270.47M7 Day Performance-22.54%0.17%0.68%2.74%1 Month Performance-38.46%3.98%4.54%5.95%1 Year Performance-78.83%9.16%73.36%25.97% Clearside Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLSDClearside Biomedical2.3598 of 5 stars$3.91-18.5%$63.00+1,513.3%-98.3%$306.50M$1.66M-10.5530Stock SplitGap DownTCRXTScan Therapeutics3.2905 of 5 stars$1.88-1.6%$7.80+314.9%-69.3%$108.39M$2.82M-1.72100Positive NewsONCYOncolytics Biotech2.4055 of 5 stars$1.28+20.8%$5.00+290.6%+33.9%$106.38MN/A-4.7430Gap UpHigh Trading VolumeHLVXHilleVax1.5945 of 5 stars$2.09-0.5%$2.00-4.3%+14.2%$105.30MN/A-1.4620Positive NewsShort Interest ↑COYACoya Therapeutics2.9622 of 5 stars$6.37+1.6%$16.50+159.0%-5.5%$104.87M$423.45K-5.146SRZNSurrozen2.9833 of 5 stars$11.36-6.9%$38.50+238.9%+34.8%$104.56M$10.65M-0.7980Positive NewsSAVACassava Sciences2.5309 of 5 stars$2.14-0.9%$2.00-6.5%-92.5%$104.35MN/A-0.8430Positive NewsADAGAdagene3.3324 of 5 stars$2.39+8.6%$7.00+192.9%-35.8%$103.69M$100K0.00260Short Interest ↓Gap UpKALAKALA BIO4.0457 of 5 stars$14.48-0.5%$17.25+19.1%+215.1%$102.16M$3.89M-2.1330Gap UpATOSAtossa Genetics1.8804 of 5 stars$0.81+2.4%$6.17+664.1%-44.8%$101.79MN/A-3.518EXOZeXoZymes1.2226 of 5 stars$12.00+0.3%N/AN/A$100.31M$70K0.0029Gap Down Related Companies and Tools Related Companies TScan Therapeutics Competitors Oncolytics Biotech Competitors HilleVax Competitors Coya Therapeutics Competitors Surrozen Competitors Cassava Sciences Competitors Adagene Competitors KALA BIO Competitors Atossa Genetics Competitors eXoZymes Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLSD) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLSD Stock Alerts